Synthetic Lethal Interactions between EGFR and PARP Inhibition in Human Triple Negative Breast Cancer Cells

Few therapeutic options exist for the highly aggressive triple negative breast cancers (TNBCs). In this study, we report that a contextual synthetic lethality can be achieved both in vitro and in vivo with combined EGFR and PARP inhibition with lapatinib and ABT-888, respectively. The mechanism invo...

Descripción completa

Detalles Bibliográficos
Autores principales: Nowsheen, Somaira, Cooper, Tiffiny, Stanley, Jennifer A., Yang, Eddy S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3469581/
https://www.ncbi.nlm.nih.gov/pubmed/23071597
http://dx.doi.org/10.1371/journal.pone.0046614

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3469581/
https://www.ncbi.nlm.nih.gov/pubmed/23071597
http://dx.doi.org/10.1371/journal.pone.0046614

Ejemplares similares